Drug
Bl1107
Bl1107: highest development phase Phase 2, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| BL1107 NCT07778888 | Phase 2 | Dry Eye Disease |
Latest
No recent events.
Follow Bl1107 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.